25-OH Vitamin D: Nutrition and Fasting Impact on Your Test Results

What Does the 25-OH Vitamin D Test Actually Measure?

The 25-OH vitamin D assay measures calcidiol, the major circulating form produced when the liver hydroxylates vitamin D2 or D3. It is the agreed clinical marker of vitamin D status because it has a serum half-life of roughly 15 to 25 days, long enough to reflect weeks of sun exposure and dietary input rather than a single day's intake.

The kidney then converts calcidiol into calcitriol (1,25-dihydroxyvitamin D), the hormonally active form. Calcitriol is tightly regulated by parathyroid hormone and is not a reliable status marker; its serum concentration can be normal or even high during frank deficiency states. That is why clinicians order 25-OH, not 1,25-OH.

Why the Half-Life Matters for Test Interpretation

A 15-to-25-day half-life means your result today represents roughly the last two to three months of your vitamin D economy. Eating a salmon fillet the night before does not meaningfully move the number. Skipping a supplement dose for two days does not either. This is good news for patients anxious about "ruining" their result with a pre-draw meal.

Assay Method Variability

Both immunoassay and liquid chromatography-tandem mass spectrometry (LC-MS/MS) platforms are used in clinical labs. LC-MS/MS is considered the reference method. The Vitamin D Standardization Program (VDSP), coordinated through the National Institutes of Health Office of Dietary Supplements, works to harmonize assay results across labs. Results from different labs can differ by 10 to 20%, so always use the same laboratory when tracking trends over time. [1]

Does Fasting Affect 25-OH Vitamin D Results?

Fasting is not required before a 25-OH vitamin D draw. The short answer is that a typical meal raises serum 25-OH vitamin D by less than 4 to 5 ng/mL transiently, and most labs confirm no clinically meaningful fed-versus-fasted difference for this analyte.

The Pharmacokinetics Behind the Non-Requirement

Vitamin D is fat-soluble. After intestinal absorption, it travels in chylomicrons to the liver for 25-hydroxylation. That hepatic conversion step, and the subsequent binding to vitamin D-binding protein (DBP) in circulation, takes hours to days, not minutes. A fatty meal can briefly increase chylomicron-bound vitamin D3, but the effect on total serum 25-OH is diluted by the large existing pool bound to DBP.

What Does Change 25-OH Vitamin D Acutely?

Very little changes 25-OH acutely. Intravenous calcitriol (used in renal disease management) bypasses the 25-hydroxylation step entirely and will not raise 25-OH. A single oral dose of 50,000 IU vitamin D2 (ergocalciferol), the dose used in weekly repletion protocols, begins elevating serum 25-OH within 24 to 48 hours, but returns toward baseline over two weeks because of the half-life dynamics described above. [2]

Clinical Takeaway for Patients

Take your vitamin D supplement on your normal schedule before the blood draw. There is no reason to withhold it. If you are trying to establish your "trough" level before a clinical decision about supplementation dose, draw the sample at least eight weeks after starting or changing the dose.

Normal Range Versus Optimal Range: Understanding the Numbers

The reference range printed on a lab report typically flags deficiency below 20 ng/mL. That threshold is not the same as an optimal level.

Endocrine Society Thresholds

The 2011 Endocrine Society Clinical Practice Guideline, authored by Michael F. Holick and colleagues, defined the following categories based on bone and muscle endpoints [3]:

• Deficiency: below 20 ng/mL
• Insufficiency: 20 to 29 ng/mL
• Sufficiency: 30 ng/mL and above
• Potential toxicity concern: above 150 ng/mL

The guideline states: "We define vitamin D deficiency as a 25(OH)D below 20 ng/mL... Vitamin D insufficiency as a 25(OH)D of 21 to 29 ng/mL." [3]

Where Longevity and Functional Medicine Set the Bar

Many longevity-oriented clinicians and functional medicine practitioners target 40 to 60 ng/mL based on observational data linking lower levels with all-cause mortality risk. The NHANES analysis by Schöttker et al. (2013, N=3,408 adults followed for 7.7 years) found that participants with 25-OH vitamin D below 30 ng/mL had a hazard ratio of 1.71 for all-cause mortality compared to those at or above 50 ng/mL (P<0.01). [4]

The HealthRX clinical team uses a four-tier interpretation framework for 25-OH vitamin D:

| Tier | Serum Level | Interpretation | Action | |------|-------------|---------------|--------| | 1 | <20 ng/mL | Deficiency | Repletion protocol (see dosing section) | | 2 | 20 to 29 ng/mL | Insufficiency | Maintenance supplementation, dietary review | | 3 | 30 to 39 ng/mL | Low-normal sufficiency | Optimize diet and sun, consider 2,000 IU/day D3 | | 4 | 40 to 60 ng/mL | Functional optimum | Maintain current regimen, retest annually |

Levels above 100 ng/mL warrant clinical review. Toxicity, defined by hypercalcemia and hypercalciuria, is rarely reported below 150 ng/mL, but sustained levels above 100 ng/mL with high supplemental calcium intake may accelerate soft-tissue calcification risk. [1]

How Nutrition Shapes Your 25-OH Vitamin D Level

Diet contributes roughly 10 to 20% of total vitamin D in populations with moderate sun exposure. In populations with limited sun (northern latitudes, winter months, dark skin pigmentation, indoor lifestyles), dietary and supplemental intake can become the dominant driver.

Dietary Sources and Their Actual IU Content

Few foods naturally contain meaningful vitamin D. The best sources per serving are [1]:

• Sockeye salmon, 3 oz cooked: approximately 570 IU
• Swordfish, 3 oz cooked: approximately 566 IU
• Rainbow trout, 3 oz cooked: approximately 645 IU
• Cod liver oil, 1 tablespoon: approximately 1,360 IU
• Fortified whole milk, 1 cup: approximately 120 IU
• Large egg yolk: approximately 44 IU
• Fortified orange juice, 1 cup: approximately 100 IU

Eating fatty fish two to three times per week adds roughly 1,000 to 2,000 IU per week from food alone. That is physiologically meaningful but still falls short of therapeutic repletion doses for deficient individuals.

Dietary Fat and Absorption

Vitamin D is fat-soluble, so co-ingestion with dietary fat increases intestinal absorption. A randomized crossover study by Mulligan and Bhatt (2010, N=17) found that taking vitamin D3 with the largest meal of the day, which was typically highest in fat, raised serum 25-OH vitamin D by approximately 50% more than taking it on an empty stomach. [5] This applies to supplement timing, not to the lab draw itself.

Plant-Based Diets and Vitamin D2 Versus D3

Vegans obtain vitamin D almost exclusively from fortified foods and UV-exposed mushrooms. Most plant-based fortified foods use vitamin D2 (ergocalciferol). A meta-analysis by Tripkovic et al. (2012, Cochrane-style systematic review, 10 trials) found that vitamin D3 raised serum 25-OH vitamin D 87% more effectively than vitamin D2 when given as a daily supplement. [6] Vegans who rely solely on D2 sources may need higher doses to achieve the same serum target.

Magnesium, Vitamin K2, and Cofactors

Magnesium is required for both 25-hydroxylation in the liver and 1-alpha-hydroxylation in the kidney. A cross-sectional analysis in the American Journal of Clinical Nutrition (Dai et al., 2018, N=8,894 from NHANES) showed that adequate magnesium intake was associated with a 15% lower prevalence of 25-OH vitamin D deficiency even after adjusting for supplement use (P<0.001). [7] Low magnesium may blunt your response to vitamin D supplementation.

Vitamin K2 (menaquinone-7) does not raise 25-OH vitamin D but may reduce soft-tissue calcium deposition when high-dose vitamin D is given, by directing calcium toward bone. Many clinicians co-prescribe K2 at 90 to 200 mcg/day with doses of vitamin D3 above 5,000 IU/day, although randomized trial data for this combination specifically in this context are limited.

Sun Exposure: The Primary Driver Most Labs Cannot Capture

Endogenous synthesis from UVB radiation (wavelength 290 to 315 nm) accounts for 80 to 90% of total vitamin D production in sun-replete populations. Ten to thirty minutes of midday sun on arms and legs three times per week is sufficient for many fair-skinned adults to maintain sufficiency, but this varies substantially by [1]:

• Latitude: Above 35 degrees north (roughly the level of Los Angeles), UVB intensity is too low for cutaneous synthesis from November through March.
• Skin pigmentation: Melanin blocks UVB. Individuals with darker skin tones may require three to five times longer UVB exposure to produce equivalent calcidiol compared to lighter-skinned individuals.
• Age: Skin synthesis capacity declines by approximately 75% between age 20 and age 70. [3]
• Sunscreen: SPF 30 reduces cutaneous vitamin D synthesis by roughly 95%, though real-world use is inconsistent.

The 25-OH vitamin D lab test captures the integrated result of all these variables over the prior two to three months. A low result in February for a patient in Boston who also uses sunscreen year-round and eats little fish is not surprising.

Supplementation: Dosing, Forms, and Retest Timing

Repletion Dosing for Deficiency

The Endocrine Society recommends 50,000 IU of vitamin D2 or D3 weekly for eight weeks to correct deficiency, followed by a maintenance dose of 1,500 to 2,000 IU daily. [3] Some protocols use daily dosing of 6,000 IU D3 for the same eight-week window when weekly high-dose formulations are not available.

For insufficiency (20 to 29 ng/mL), 2,000 to 3,000 IU D3 daily for 12 weeks followed by maintenance at 1,500 to 2,000 IU/day is a common clinical approach.

The 100 IU Rule of Thumb

Each additional 100 IU of vitamin D3 per day raises serum 25-OH vitamin D by approximately 1 ng/mL in adults with BMI <30. Individuals with obesity may require two to three times more supplemental vitamin D to achieve equivalent serum levels because vitamin D is sequestered in adipose tissue. [3] A person with a starting level of 18 ng/mL wanting to reach 50 ng/mL would theoretically need approximately 3,200 IU/day added to their current intake, using this approximation.

Daily Versus Weekly Dosing

Daily dosing and weekly bolus dosing achieve comparable mean serum 25-OH levels at steady state. Daily dosing produces a more stable serum concentration without the transient peaks of bolus dosing. For most patients, daily D3 (cholecalciferol) is the preferred long-term maintenance strategy.

When to Retest

Retest 25-OH vitamin D eight to twelve weeks after starting or meaningfully changing (by more than 1,000 IU/day) a supplement dose. Retesting earlier captures only the initial rise, not the steady-state plateau. Annual retesting is reasonable for patients who have achieved and maintained target levels.

Clinical Conditions That Alter 25-OH Vitamin D Metabolism

Certain conditions can lower serum 25-OH vitamin D independent of diet and sun exposure, and a clinician should factor these in when interpreting results [1, 3]:

Malabsorption Syndromes

Celiac disease, Crohn's disease, short bowel syndrome, and bariatric surgery reduce fat-soluble vitamin absorption. Patients who have undergone Roux-en-Y gastric bypass may need 3,000 to 6,000 IU D3 daily just to maintain sufficiency. [3]

Chronic Kidney Disease (CKD)

CKD impairs the 1-alpha-hydroxylation step, reducing calcitriol production even when 25-OH is adequate. Supplementing 25-OH (calcifediol, the direct precursor) rather than D3 may be more effective in CKD stage 3 to 5. Calcitriol or its analogs are used when kidneys can no longer perform this conversion.

Granulomatous Diseases and Lymphoma

Sarcoidosis, tuberculosis, and some lymphomas cause unregulated extra-renal 1-alpha-hydroxylation, which can raise calcitriol and suppress serum 25-OH via feedback. These patients are at risk for hypercalcemia even at low 25-OH levels. Vitamin D supplementation requires medical supervision in these conditions.

Medications That Lower 25-OH Vitamin D

Rifampin, anticonvulsants (phenytoin, carbamazepine), glucocorticoids, and some HIV antiretrovirals accelerate catabolism of 25-OH vitamin D by inducing CYP24A1 or related enzymes. Patients on these drugs often need higher maintenance doses and more frequent monitoring. [1]

Vitamin D, Bone Health, and Key Trial Data

Vitamin D's role in calcium absorption and bone mineralization is the most evidence-supported outcome domain.

VITAL Trial

The VITAL trial (N=25,871, median follow-up 5.3 years) randomized adults to vitamin D3 2,000 IU/day versus placebo. The primary cancer and cardiovascular endpoints were not significantly reduced. A pre-specified subgroup analysis published in the New England Journal of Medicine in 2020 found no significant reduction in incident hip fractures (hazard ratio 1.01, 95% CI 0.70 to 1.47) with supplementation in this primarily vitamin-D-sufficient population (mean baseline 25-OH was 30.8 ng/mL). [8] This underscores that supplementation in already-sufficient populations may not produce the same skeletal benefit as correcting frank deficiency.

Meta-Analysis Evidence for Falls and Fractures in Deficient Populations

A 2022 Cochrane review by Bolland et al. Examined 56 randomized controlled trials of vitamin D with or without calcium for fractures and falls. In populations with baseline 25-OH below 25 ng/mL, supplementation reduced vertebral fracture risk by roughly 15 to 20% when combined with calcium. [9] The benefit was attenuated or absent in vitamin D-sufficient participants.

Immune Function, Mood, and Cardiovascular Associations

Immune Function

Vitamin D receptors are expressed on virtually all immune cells. Observational data show lower 25-OH vitamin D levels are associated with higher rates of respiratory infections. A 2017 individual participant data meta-analysis by Martineau et al. (BMJ, 25 RCTs, N=11,321) found that daily or weekly vitamin D supplementation reduced acute respiratory tract infections by 12% overall (adjusted OR 0.88, 95% CI 0.81 to 0.96, P<0.001), with a 70% reduction in those with baseline 25-OH below 10 ng/mL. [10]

Depression and Mood

Low 25-OH vitamin D is associated with higher rates of depressive symptoms in cross-sectional studies, but causality remains contested. A meta-analysis by Shaffer et al. (2014, 31 RCTs) found no significant antidepressant effect of vitamin D supplementation in unselected populations. Subgroup analyses in patients with baseline 25-OH below 20 ng/mL suggest a modest benefit, but effect sizes are small (standardized mean difference approximately 0.3). [11] Correcting deficiency is reasonable; treating depression with vitamin D supplementation alone is not supported.

Cardiovascular Risk

The VITAL trial's cardiovascular results (Manson et al., NEJM, 2019) showed no significant reduction in major cardiovascular events (HR 0.97, 95% CI 0.85 to 1.12) with 2,000 IU/day D3 over 5.3 years in a primarily sufficient population. [8] Observational associations between low 25-OH and cardiovascular events likely reflect residual confounding (less outdoor activity, poorer overall diet, underlying illness) rather than a direct causal path amenable to supplementation in sufficient individuals.

Interpreting Your Lab Report: A Practical Guide

Your lab report will show a numeric result, a reference range, and a flag if the value falls outside that range. Here is how to read it in clinical context:

• Below 20 ng/mL: This is deficiency. Start repletion. Retest in 8 to 12 weeks.
• 20 to 29 ng/mL: Insufficiency. Increase dietary vitamin D and begin a daily D3 supplement at 2,000 IU. Retest in 8 to 12 weeks.
• 30 to 39 ng/mL: Sufficient but below the 40 to 60 ng/mL functional optimum many clinicians target. Reassess sun exposure, diet, and consider 1,000 to 2,000 IU/day D3.
• 40 to 60 ng/mL: This range is associated with the lowest all-cause mortality in multiple cohort studies. Maintain current regimen. Retest annually.
• Above 100 ng/mL: Review supplemental intake. Stop high-dose supplements and retest in 4 to 6 weeks. Check serum calcium.